2022-08-012023-07-312023-07-31false10294283Paraesthetic Surgical Limited2024-03-2186220iso4217:GBPxbrli:pure102942832022-08-01102942832023-07-31102942832022-08-012023-07-31102942832021-08-01102942832022-07-31102942832021-08-012022-07-3110294283bus:SmallEntities2022-08-012023-07-3110294283bus:AuditExempt-NoAccountantsReport2022-08-012023-07-3110294283bus:AbridgedAccounts2022-08-012023-07-3110294283bus:PrivateLimitedCompanyLtd2022-08-012023-07-3110294283core:WithinOneYear2023-07-3110294283core:AfterOneYear2023-07-3110294283core:WithinOneYear2022-07-3110294283core:AfterOneYear2022-07-3110294283core:ShareCapital2023-07-3110294283core:SharePremium2023-07-3110294283core:RevaluationReserve2023-07-3110294283core:OtherReservesSubtotal2023-07-3110294283core:RetainedEarningsAccumulatedLosses2023-07-3110294283core:ShareCapital2022-07-3110294283core:SharePremium2022-07-3110294283core:RevaluationReserve2022-07-3110294283core:OtherReservesSubtotal2022-07-3110294283core:RetainedEarningsAccumulatedLosses2022-07-3110294283core:LandBuildings2023-07-3110294283core:PlantMachinery2023-07-3110294283core:Vehicles2023-07-3110294283core:FurnitureFittings2023-07-3110294283core:OfficeEquipment2023-07-3110294283core:NetGoodwill2023-07-3110294283core:IntangibleAssetsOtherThanGoodwill2023-07-3110294283core:ListedExchangeTraded2023-07-3110294283core:UnlistedNon-exchangeTraded2023-07-3110294283core:LandBuildings2022-07-3110294283core:PlantMachinery2022-07-3110294283core:Vehicles2022-07-3110294283core:FurnitureFittings2022-07-3110294283core:OfficeEquipment2022-07-3110294283core:NetGoodwill2022-07-3110294283core:IntangibleAssetsOtherThanGoodwill2022-07-3110294283core:ListedExchangeTraded2022-07-3110294283core:UnlistedNon-exchangeTraded2022-07-3110294283core:LandBuildings2022-08-012023-07-3110294283core:PlantMachinery2022-08-012023-07-3110294283core:Vehicles2022-08-012023-07-3110294283core:FurnitureFittings2022-08-012023-07-3110294283core:OfficeEquipment2022-08-012023-07-3110294283core:NetGoodwill2022-08-012023-07-3110294283core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3110294283core:ListedExchangeTraded2022-08-012023-07-3110294283core:UnlistedNon-exchangeTraded2022-08-012023-07-3110294283core:MoreThanFiveYears2022-08-012023-07-3110294283core:Non-currentFinancialInstruments2023-07-3110294283core:Non-currentFinancialInstruments2022-07-3110294283dpl:CostSales2022-08-012023-07-3110294283dpl:DistributionCosts2022-08-012023-07-3110294283core:LandBuildings2022-08-012023-07-3110294283core:PlantMachinery2022-08-012023-07-3110294283core:Vehicles2022-08-012023-07-3110294283core:FurnitureFittings2022-08-012023-07-3110294283core:OfficeEquipment2022-08-012023-07-3110294283dpl:AdministrativeExpenses2022-08-012023-07-3110294283core:NetGoodwill2022-08-012023-07-3110294283core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3110294283dpl:GroupUndertakings2022-08-012023-07-3110294283dpl:ParticipatingInterests2022-08-012023-07-3110294283dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3110294283core:ListedExchangeTraded2022-08-012023-07-3110294283dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3110294283core:UnlistedNon-exchangeTraded2022-08-012023-07-3110294283dpl:CostSales2021-08-012022-07-3110294283dpl:DistributionCosts2021-08-012022-07-3110294283core:LandBuildings2021-08-012022-07-3110294283core:PlantMachinery2021-08-012022-07-3110294283core:Vehicles2021-08-012022-07-3110294283core:FurnitureFittings2021-08-012022-07-3110294283core:OfficeEquipment2021-08-012022-07-3110294283dpl:AdministrativeExpenses2021-08-012022-07-3110294283core:NetGoodwill2021-08-012022-07-3110294283core:IntangibleAssetsOtherThanGoodwill2021-08-012022-07-3110294283dpl:GroupUndertakings2021-08-012022-07-3110294283dpl:ParticipatingInterests2021-08-012022-07-3110294283dpl:GroupUndertakingscore:ListedExchangeTraded2021-08-012022-07-3110294283core:ListedExchangeTraded2021-08-012022-07-3110294283dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-08-012022-07-3110294283core:UnlistedNon-exchangeTraded2021-08-012022-07-3110294283core:NetGoodwill2023-07-3110294283core:IntangibleAssetsOtherThanGoodwill2023-07-3110294283core:LandBuildings2023-07-3110294283core:PlantMachinery2023-07-3110294283core:Vehicles2023-07-3110294283core:FurnitureFittings2023-07-3110294283core:OfficeEquipment2023-07-3110294283core:AfterOneYear2023-07-3110294283core:WithinOneYear2023-07-3110294283core:ListedExchangeTraded2023-07-3110294283core:UnlistedNon-exchangeTraded2023-07-3110294283core:ShareCapital2023-07-3110294283core:SharePremium2023-07-3110294283core:RevaluationReserve2023-07-3110294283core:OtherReservesSubtotal2023-07-3110294283core:RetainedEarningsAccumulatedLosses2023-07-3110294283core:NetGoodwill2022-07-3110294283core:IntangibleAssetsOtherThanGoodwill2022-07-3110294283core:LandBuildings2022-07-3110294283core:PlantMachinery2022-07-3110294283core:Vehicles2022-07-3110294283core:FurnitureFittings2022-07-3110294283core:OfficeEquipment2022-07-3110294283core:AfterOneYear2022-07-3110294283core:WithinOneYear2022-07-3110294283core:ListedExchangeTraded2022-07-3110294283core:UnlistedNon-exchangeTraded2022-07-3110294283core:ShareCapital2022-07-3110294283core:SharePremium2022-07-3110294283core:RevaluationReserve2022-07-3110294283core:OtherReservesSubtotal2022-07-3110294283core:RetainedEarningsAccumulatedLosses2022-07-3110294283core:NetGoodwill2021-08-0110294283core:IntangibleAssetsOtherThanGoodwill2021-08-0110294283core:LandBuildings2021-08-0110294283core:PlantMachinery2021-08-0110294283core:Vehicles2021-08-0110294283core:FurnitureFittings2021-08-0110294283core:OfficeEquipment2021-08-0110294283core:AfterOneYear2021-08-0110294283core:WithinOneYear2021-08-0110294283core:ListedExchangeTraded2021-08-0110294283core:UnlistedNon-exchangeTraded2021-08-0110294283core:ShareCapital2021-08-0110294283core:SharePremium2021-08-0110294283core:RevaluationReserve2021-08-0110294283core:OtherReservesSubtotal2021-08-0110294283core:RetainedEarningsAccumulatedLosses2021-08-0110294283core:AfterOneYear2022-08-012023-07-3110294283core:WithinOneYear2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:CostValuation2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-08-012023-07-3110294283core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3110294283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3110294283core:Non-currentFinancialInstrumentscore:CostValuation2022-07-3110294283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-3110294283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-3110294283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-3110294283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-3110294283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-3110294283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-3110294283bus:Director12022-08-012023-07-3110294283bus:Director22022-08-012023-07-31

Paraesthetic Surgical Limited

Registered Number
10294283
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2023

Paraesthetic Surgical Limited
Company Information
for the year from 1 August 2022 to 31 July 2023

Directors

Lohana, Parkash, Dr
Lohana, Rekha, Dr

Registered Address

10 Queensway
Lincoln
LN2 4AH

Registered Number

10294283 (England and Wales)
Paraesthetic Surgical Limited
Balance Sheet as at
31 July 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets33,6792,538
3,6792,538
Current assets
Debtors4571,907328,880
Cash at bank and on hand201,58760,829
773,494389,709
Creditors amounts falling due within one year(130,025)(60,584)
Net current assets (liabilities)643,469329,125
Total assets less current liabilities647,148331,663
Net assets647,148331,663
Capital and reserves
Called up share capital100100
Profit and loss account647,048331,563
Shareholders' funds647,148331,663
The financial statements were approved and authorised for issue by the Board of Directors on 21 March 2024, and are signed on its behalf by:
Lohana, Parkash, Dr
Director
Registered Company No. 10294283
Paraesthetic Surgical Limited
Notes to the Financial Statements
for the year ended 31 July 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20232022
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 August 225,100
Additions1,704
At 31 July 236,804
Depreciation and impairment
At 01 August 222,562
Charge for year563
At 31 July 233,125
Net book value
At 31 July 233,679
At 31 July 222,538
4.Debtors: amounts due within one year

2023

2022

££
Trade debtors / trade receivables52,70736,380
Total52,70736,380
Included within Debtors Due Within One Year is £292,500 (2021 nil). It is considered highly that this loan is a long term loan and will be repaid in more than one year.